Join
Live feed
·
PRReleasevia Quantisnow
Catalyst Pharmaceuticals Inc. logo

Catalyst Pharmaceuticals Completes the Acquisition of U.S. Rights to FYCOMPA® (Perampanel) CIII

ByQuantisnow·Wall Street's wire, on your screen.
CPRX· Catalyst Pharmaceuticals Inc.
Health Care

This insight was delivered by - Wall Street's wire, on your screen. Quantisnow is a real-time market data and news platform for retail investors, aggregating SEC filings, FDA approvals, analyst ratings, insider trading, and press releases into a single customizable feed. Track CPRX (Catalyst Pharmaceuticals Inc.) and more on Quantisnow.